Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TT2-32 TFA induces a biphasic activation of phosphotyrosine phosphatase activity in human colon tumor cell line, SW620
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 133.00 | |
5 mg | In stock | $ 302.00 | |
10 mg | In stock | $ 453.00 | |
25 mg | In stock | $ 747.00 | |
50 mg | In stock | $ 1,050.00 | |
100 mg | In stock | $ 1,420.00 | |
500 mg | In stock | $ 2,830.00 |
Description | TT2-32 TFA induces a biphasic activation of phosphotyrosine phosphatase activity in human colon tumor cell line, SW620 |
In vitro | TT2-32 strongly stimulates PTPase activity in a biphasic manner in a SW620 human colon tumor cell line as an early step in its signal transduction process.TT2-32-induced activation of PTPases may be an important signaling pathway in the inhibition of cell proliferation in colon carcinomas[1]. |
Molecular Weight | 1061.16 |
Formula | C47H59F3N10O11S2 |
CAS No. | 2703745-48-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/ml
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TT-232 TFA(147159-51-1 free base) 2703745-48-4 Others 147159-51-1 free base TT232 TFA(147159511 free base) 147159-51-1 TT 232 TFA(147159 51 1 free base) TT-232 TFA inhibitor inhibit